BioCryst's total assets for Q4 2024 were $490.42M, a decrease of -0.17% from the previous quarter. BCRX total liabilities were $966.35M for the fiscal quarter, a 0.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.